Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,847 | 1,089 | 98.2% |
| Gift | $262.89 | 1 | 1.4% |
| Education | $62.06 | 12 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $2,939 | 148 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,359 | 163 | $0 (2024) |
| Novo Nordisk Inc | $2,027 | 121 | $0 (2024) |
| PFIZER INC. | $1,700 | 143 | $0 (2024) |
| GlaxoSmithKline, LLC. | $946.08 | 62 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $940.50 | 53 | $0 (2024) |
| Merck Sharp & Dohme LLC | $864.68 | 72 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $794.48 | 47 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $669.22 | 33 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $572.77 | 36 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,405 | 120 | Novo Nordisk Inc ($364.10) |
| 2023 | $2,197 | 114 | Lilly USA, LLC ($362.06) |
| 2022 | $2,293 | 135 | AstraZeneca Pharmaceuticals LP ($307.33) |
| 2021 | $2,095 | 116 | Lilly USA, LLC ($381.50) |
| 2020 | $1,454 | 93 | Lilly USA, LLC ($313.58) |
| 2019 | $2,279 | 152 | Lilly USA, LLC ($590.16) |
| 2018 | $2,677 | 185 | AstraZeneca Pharmaceuticals LP ($493.70) |
| 2017 | $2,773 | 187 | Lilly USA, LLC ($380.51) |
All Payment Transactions
1,102 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Bone Health | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Diabetes Care | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $32.48 | General |
| Category: Cardio-renal | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: Obesity | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: PAIN | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: Immunology | ||||||
| 10/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: VACCINES | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $34.37 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 51 | 7,547 | 12,911 | $1.1M | $471,156 |
| 2022 | 53 | 8,023 | 13,379 | $1.1M | $508,449 |
| 2021 | 49 | 8,597 | 13,825 | $1.0M | $420,932 |
| 2020 | 45 | 7,294 | 10,277 | $858,559 | $320,162 |
All Medicare Procedures & Services
198 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,009 | 2,180 | $464,455 | $206,143 | 44.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 557 | 952 | $137,088 | $63,047 | 46.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 203 | 203 | $46,893 | $28,000 | 59.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 221 | 221 | $19,890 | $15,897 | 79.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 561 | 1,038 | $38,863 | $13,605 | 35.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 616 | 1,156 | $30,888 | $11,965 | 38.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 352 | 353 | $15,573 | $11,688 | 75.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 663 | 1,371 | $20,565 | $11,491 | 55.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 42 | 269 | $36,580 | $10,424 | 28.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 122 | 122 | $21,960 | $10,075 | 45.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 39 | 237 | $32,100 | $9,577 | 29.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 35 | 35 | $10,600 | $9,399 | 88.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 306 | 478 | $22,437 | $7,865 | 35.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 591 | 1,019 | $22,989 | $7,747 | 33.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 27 | 28 | $13,496 | $6,288 | 46.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 283 | 558 | $15,133 | $5,303 | 35.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 79 | 84 | $12,600 | $4,224 | 33.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 23 | 23 | $5,750 | $4,056 | 70.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 19 | 19 | $5,821 | $3,357 | 57.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 50 | 263 | $12,887 | $2,882 | 22.4% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 126 | 126 | $4,969 | $2,759 | 55.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 37 | 38 | $5,510 | $2,549 | 46.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 64 | 131 | $3,513 | $2,125 | 60.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 119 | 140 | $5,897 | $2,069 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,220 | $1,900 | 36.4% |
About Dr. John Mcdermott, DO
Dr. John Mcdermott, DO is a Family Medicine healthcare provider based in Florida, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386663854.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Mcdermott, DO has received a total of $18,172 in payments from pharmaceutical and medical device companies, with $2,405 received in 2024. These payments were reported across 1,102 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($17,847).
As a Medicare-enrolled provider, Mcdermott has provided services to 31,461 Medicare beneficiaries, totaling 50,392 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 198 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Florida, NY
- Active Since 07/18/2006
- Last Updated 09/27/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1386663854
Products in Payments
- TRULICITY (Drug) $1,781
- FARXIGA (Drug) $1,559
- Ozempic (Drug) $854.14
- XARELTO (Drug) $654.53
- ELIQUIS (Drug) $576.98
- MOUNJARO (Drug) $523.88
- CHANTIX (Drug) $500.13
- JANUVIA (Drug) $485.20
- JARDIANCE (Drug) $459.76
- Saxenda (Drug) $386.99
- Vascepa (Drug) $386.70
- ENTRESTO (Drug) $337.97
- PREVNAR 20 (Biological) $324.84
- TRADJENTA (Drug) $306.26
- Kerendia (Drug) $302.56
- G8 Elution Buffer No. 1, 800mL (Medical Supply) $262.89
- AJOVY (Biological) $262.04
- BEVESPI AEROSPHERE (Drug) $249.01
- SYMBICORT (Drug) $244.09
- BREZTRI (Drug) $227.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Florida
John Dermigny, D.o, D.O
Family Medicine — Payments: $4,056
Victoria Avidano, Dnp, DNP
Family Medicine — Payments: $1,982
Robin Santiago-Delgado, M.d, M.D
Family Medicine — Payments: $261.91
Dr. Abdias De La Rosa Serrano, Md, MD
Family Medicine